Liverpool firm develops breakthrough disease test
A Liverpool firm has filed a patent for a 'game-changer' novel technology that enables lateral flow tests, currently used for COVID-19 testing, to detect a range of other diseases. Tony McDonough reports Lateral flow tests (LFTs)…